Response of diabetic papillopathy to intravitreal bevacizumab (Q38265343)

1 September 2017

0 references

Response of diabetic papillopathy to intravitreal bevacizumab (English)

1 reference

1 September 2017

Hassan Al-Dhibi

1

1 reference

1 September 2017

Arif O Khan

series ordinal

2

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

Middle East African Journal of Ophthalmology

1 September 2017

1 reference

1 September 2017

18

1 reference

1 September 2017

3

1 reference

1 September 2017

243-245

1 reference

Bevacizumab (Avastin) for the treatment of ocular disease

1 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Diabetic papillopathy with macular star mimicking clinically significant diabetic macular edema

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Intravitreal bevacizumab for diabetic papillopathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Pathophysiological consequences of VEGF-induced vascular permeability

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Diabetic papillopathy in type II diabetic patients

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Disc swelling in an adult diabetic patient

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162739

Diabetic papillopathy. Patient characteristics and fundus findings

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21887082

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21887082

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4103/0974-9233.84056

1 reference

release_q3pn7fx52jc3rhtmcegzyhl6qy

1 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q3pn7fx52jc3rhtmcegzyhl6qy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

1 September 2017

1 reference